Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT01325012
Other study ID # Subgluteal vs Popliteal
Secondary ID
Status Terminated
Phase Phase 4
First received March 28, 2011
Last updated March 27, 2013
Start date March 2011
Est. completion date March 2013

Study information

Verified date March 2013
Source University of California, San Diego
Contact n/a
Is FDA regulated No
Health authority United States: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

To determine the relationship between perineural catheter location along the sciatic nerve (popliteal versus subgluteal placement) and infusion effects for ultrasound-guided continuous sciatic nerve blocks.


Recruitment information / eligibility

Status Terminated
Enrollment 2
Est. completion date March 2013
Est. primary completion date March 2013
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- undergoing foot surgery with a sciatic perineural catheter for postoperative analgesia

- spending the first postoperative night hospitalized

- age 18 years or older

Exclusion Criteria:

- pregnancy

- inability to communicate with the investigators and hospital staff

- incarceration

- clinical neuropathy in the surgical extremity

Study Design

Allocation: Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
Subgluteal Sciatic Nerve Block
Patients randomized to this group will receive a sciatic nerve block with the catheter tip insertion at the subgluteal location 1-3 cm caudad to the inferior border of the gluteus maximus muscle. After catheter placement, outcome measures will be assessed.
Popliteal Sciatic Nerve Block
Patients randomized to this group will receive a sciatic nerve block with the catheter tip insertion at the popliteal location 1-3 cm cephalad to the sciatic bifurcation. After Catheter placement outcome measures will be assessed.

Locations

Country Name City State
United States UCSD Medical Center, Thornton La Jolla California
United States UCSD Medical Center Hillcrest San Diego California

Sponsors (1)

Lead Sponsor Collaborator
University of California, San Diego

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Muscle Strength (MVIC) of the hamstring muscles We will evaluate hamstring strength which is innervated by the sciatic nerve with an isometric force electromechanical dynamometer to measure the force produced during a maximum voluntary isometric contraction (MVIC) in a seated position with the knees flexed at 90ยบ 08:00-09:00 morning after surgery as a percentage of baseline No
Secondary Sensory Effect We will evaluate tolerance of transcutaneous electrical stimulation. Electrocardiogram pads will be placed on the plantar and dorsal aspects of the foot, and attached to a nerve stimulator. The current will be increased from 0 mA until subjects described a "buzzing" sensation (not painful), at which time the current will be recorded as the tolerated level and the nerve stimulator turned off. 08:00-09:00 morning after surgery No
Secondary Pain Scores Surgical pain scores both average and worse as collected by nursing staff; and also the average and worse pain during the primary endpoint measurement from leaving the PACU until 08:00 the morning after surgery No
Secondary Sleep Disturbances Total number of times patient woke in the night due to surgical pain. recorded at 08:00-09:00 the morning after surgery for the previous night No
Secondary Total Infusion Total infusiond duration in time and volume and total number of boluses delivered via catheter. recorded at 08:00-09:00 the morning following Surgery No
Secondary Anesthetic Leakage Leakage from the catheter site noted by patient. recorded at 08:00-09:00 the morning following Surgery No
Secondary analgesic consumption Hourly analgesic consumption. end of PACU stay until 08:00-09:00 the morning following surgery No
See also
  Status Clinical Trial Phase
Completed NCT01229696 - Continuous Popliteal Nerve Blocks: Effect of Perineural Catheter Tip Location Relative to the Sciatic Nerve Bifurcation on Postoperative Analgesia Phase 4
Completed NCT01049906 - Popliteal Sciatic Nerve Block Catheter Placement for Foot Surgery N/A
Terminated NCT05354791 - Pre-post Spinal Popliteal Block
Enrolling by invitation NCT05425979 - Mepivacaine Versus Bupivacaine Onset Time in Ultrasound-guided Ankle Blocks Phase 4
Terminated NCT01615939 - A Study Comparing Continuous Sciatic Nerve Block to Single Shot Sciatic Nerve Block Phase 4
Enrolling by invitation NCT06465992 - Liposomal Bupivacaine With Dexamethasone for Foot Surgery Phase 4
Completed NCT05368012 - MIDCAB (Mid-Calf Block) for Foot Surgery Phase 4
Enrolling by invitation NCT04575688 - Periarticular Injection Versus Popliteal Block Phase 4
Recruiting NCT01546077 - Placement of Perineural Catheters in the Popliteal Region Phase 4
Recruiting NCT06309381 - Influence of Sensory Block Duration on Rebound Pain After Outpatient Foot Surgery Under Popliteal Sciatic Nerve Block.
Completed NCT04134962 - Evaluation of a New Tool for Measuring Hindfoot Alignment Under Load and in 3D.
Enrolling by invitation NCT04872322 - Effect of Ropivacaine During Popliteal Nerve Block in Foot and Ankle Surgery Phase 3